Open AccessA Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature Review
Author(s) -
Takahiro Fuji,
Jun Arai,
Yumi Otoyama,
Yuta Nio,
Ikuya Sugiura,
Yoko Nakajima,
Atsushi Kajiwara,
Yūki Ichikawa,
Shojiro Uozumi,
Yuu Shimozuma,
Manabu Uchikoshi,
Masashi Sakaki,
Hisako Nozawa,
Kenji Momo,
Tadanori Sasaki,
Hitoshi Yoshida
Publication year - 2022
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s383769
Subject(s) - medicine , atezolizumab , bevacizumab , gastroenterology , hepatocellular carcinoma , diarrhea , colitis , prednisolone , chemotherapy , adverse effect , radiology , cancer , nivolumab , immunotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom